| 000 | 01587 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516080043.0 | ||
| 264 | 0 | _c20120817 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.06059-11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRequena-Méndez, Ana | |
| 245 | 0 | 0 |
_aPharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMay 2012 |
||
| 300 |
_a2357-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Complications _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 |
_aRifampin _xblood |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xblood |
| 700 | 1 | _aDavies, Geraint | |
| 700 | 1 | _aArdrey, Alison | |
| 700 | 1 | _aJave, Oswaldo | |
| 700 | 1 | _aLópez-Romero, Sonia L | |
| 700 | 1 | _aWard, Stephen A | |
| 700 | 1 | _aMoore, David A J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 56 _gno. 5 _gp. 2357-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.06059-11 _zAvailable from publisher's website |
| 999 |
_c21542054 _d21542054 |
||